The global single-use bioprocessing market is projected to grow from USD 18.01 billion in 2025 to USD 33.67 billion by 2030, registering a CAGR of 13.3% during the forecast period. This rapid expansion is driven by the increasing adoption of single-use technologies among CDMOs and CMOs, rising demand for cost-efficient production, reduced risk of cross-contamination, and lower capital investment requirements.
Market Overview: Why Single-Use Bioprocessing is Gaining Momentum
The single-use bioprocessing market is witnessing strong growth as biopharmaceutical companies shift toward disposable technologies. These systems significantly streamline production by eliminating the need for complex cleaning and sterilization processes associated with traditional stainless-steel equipment.
Technological advancements in single-use bioreactors, filtration systems, and chromatography solutions have further enhanced scalability, flexibility, and operational efficiency, making them a preferred choice in modern biomanufacturing.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231651297
Key Market Driver: Higher Productivity & Reduced Contamination Risk
One of the major drivers of the single-use bioprocessing market is the ability to improve productivity while minimizing contamination risks.
Single-use systems:
- Eliminate time-consuming cleaning and validation steps
- Enable faster product changeovers and process transitions
- Maximize equipment utilization and throughput
Their closed, sterile design reduces microbial contamination and cross-batch risks, ensuring high product quality and compliance with strict regulatory standards. This ultimately accelerates time-to-market for biologics and boosts overall revenue growth.
Emerging Opportunity: Untapped Growth in Developing Economies
Emerging markets such as China, India, Brazil, and Mexico present significant growth opportunities for the single-use bioprocessing market.
Key growth factors include:
- Rising healthcare demand
- Expanding biopharmaceutical infrastructure
- Favorable government initiatives
- Increasing investments in biologics manufacturing
While North America and Europe remain mature markets, these developing regions are becoming key expansion hubs for industry players.
Regional Insights: North America Leads the Market
North America dominated the single-use bioprocessing market in 2024, supported by:
- High pharmaceutical R&D spending
- Strong demand for biosimilars
- Advanced healthcare infrastructure
- Significant investments by biopharma companies and CMOs
The U.S. continues to hold the largest market share, driven by its leadership in biopharmaceutical innovation and manufacturing capabilities.
Application Analysis: Filtration Segment Holds Largest Share
Based on application, the filtration segment accounted for the largest share of the single-use bioprocessing market in 2024.
This dominance is due to:
- Extensive use in pharmaceutical manufacturing
- Increasing filtration requirements in biologics production
- Higher demand for filters compared to accessories and consumables
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=231651297
Key Companies in the Single-Use Bioprocessing Market
Leading players shaping the competitive landscape include:
- Sartorius AG
- Danaher Corporation
- Thermo Fisher Scientific
- Merck KGaA
- Avantor, Inc.
- Repligen Corporation
- Entegris
- Getinge AB
- Parker Hannifin Corporation
- Alfa Laval
- Saint-Gobain
- Eppendorf SE
- Corning Incorporated
- Lonza
Competitive Insights
Merck KGaA
A major leader in the single-use bioprocessing market, Merck KGaA is strengthening its global presence through:
- Continuous R&D investments
- Expansion of manufacturing facilities across Europe and Asia
- Focus on scalability, flexibility, and sustainable solutions
Danaher Corporation
Through its subsidiary Cytiva, Danaher has built a strong position in the single-use bioprocessing market. Its strategies include:
- Strategic acquisitions (including Pall Corporation)
- Expansion of innovation hubs (e.g., South Korea biotech cluster)
- Advanced training and technical support for biopharma companies
Enquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=231651297
Conclusion: Future Outlook of the Single-Use Bioprocessing Market The single-use bioprocessing market is poised for robust growth, driven by technological advancements, increasing biologics demand, and expansion into emerging markets. With advantages such as improved efficiency, reduced contamination risks, and lower capital investment, single-use systems are set to redefine the future of biomanufacturing.
